CLASS ACTION UPDATE for MMSI, EXC and OPRA: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

NEW YORK, NY / ACCESSWIRE / January 31, 2020 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. Further details about the cases can be found at the links provided. There is no cost or obligation to you.

MMSI Shareholders Click Here: https://www.zlk.com/pslra-1/merit-medical-systems-inc-loss-form?prid=5391&wire=1
EXC Shareholders Click Here: https://www.zlk.com/pslra-1/exelon-corporation-loss-form?prid=5391&wire=1
OPRA Shareholders Click Here: https://www.zlk.com/pslra-1/opera-limited-loss-form?prid=5391&wire=1

* ADDITIONAL INFORMATION BELOW *

Merit Medical Systems, Inc. (NASDAQ:MMSI)

MMSI Lawsuit on behalf of: investors who purchased February 26, 2019 - October 30, 2019
Lead Plaintiff Deadline : February 3, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/merit-medical-systems-inc-loss-form?prid=5391&wire=1

According to the filed complaint, during the class period, Merit Medical Systems, Inc. made materially false and/or misleading statements and/or failed to disclose that: (a) the integrations of acquired companies Cianna Medical, Inc. and Vascular Insights, LLC, including their products, sales people, and R&D facilities, had caused operational disruptions and reduced sales and were months behind schedule; (b) sales of acquired company products had slowed substantially due to pre-acquisition pipeline fill, in particular for Vascular Insights products which, as late as July 2019, had zero orders during FY19; and (c) in light of the foregoing, the Company's reported financial guidance for FY19 and FY20 was made without a reasonable basis.

Exelon Corporation (NYSE:EXC)

EXC Lawsuit on behalf of: investors who purchased February 9, 2019 - November 1, 2019
Lead Plaintiff Deadline : February 14, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/exelon-corporation-loss-form?prid=5391&wire=1

According to the filed complaint, during the class period, Exelon Corporation made materially false and/or misleading statements and/or failed to disclose that: (i) Exelon and/or its employees were engaged in unlawful lobbying activities; (ii) the foregoing increased the risk of a criminal investigation into Exelon; (iii) Exelon subsidiary Commonwealth Edison's revenues were in part the product of unlawful conduct and thus unsustainable; and (iv) that, as a result, the Company's public statements were materially false and misleading at all relevant times.

Opera Limited (NASDAQ:OPRA)

OPRA Lawsuit on behalf of: investors who purchased (a) Opera American depositary shares pursuant and/or traceable to the Company's initial public offering commenced on or about July 27, 2018 and/or (b) Opera securities between July 27, 2018 and January 15, 2020,
Lead Plaintiff Deadline : March 24, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/opera-limited-loss-form?prid=5391&wire=1

According to the filed complaint, (i) Opera's sustainable growth and market opportunity for its browser applications was significantly overstated; (ii) Defendants' funded, owned, or otherwise controlled loan services applications and/or businesses relied on predatory lending practices; (iii) all the foregoing, once revealed, were reasonably likely to have a material negative impact on Opera's financial prospects, especially with respect to its lending applications' continued availability on the Google Play Store; and (iv) as a result, the Offering Documents and Defendants' statements were materially false and/or misleading and failed to state information required to be stated therein.

You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP